Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Alliance Resource Partners
ARLP
$3.2B
| $1.61M | ﹤0.01% |
+74,390
| New | +$1.69M |
|
2352
Citi Trends
CTRN
$629M
| $1.61M | ﹤0.01% |
94,600
-41,500
| -30% | -$723K |
|
2353
Navios Maritime Partners
NMM
$2.31B
| $1.61M | ﹤0.01% |
51,787
+46,634
| +905% | +$1.29M |
|
2354
Orion Energy Systems
OESX
$79.7M
| $1.6M | ﹤0.01% |
80,750
+5,400
| +7% | +$108K |
|
|
AVEO
2355
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $1.6M | ﹤0.01% |
270,440
-3,950
| -1% | -$28.5K |
|
|
MATR
2356
DELISTED
Mattersight Corp.
MATR
| $1.59M | ﹤0.01% |
453,800
-11,000
| -2% | -$40.1K |
|
2357
NetSol Technologies
NTWK
$48.7M
| $1.58M | ﹤0.01% |
310,720
-46,182
| -13% | -$235K |
|
|
SPNE
2358
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $1.58M | ﹤0.01% |
201,500
+40,700
| +25% | +$294K |
|
2359
Emcor
EME
$36.7B
| $1.57M | ﹤0.01% |
+25,000
| New | +$1.66M |
|
|
ATAXZ
2360
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
| $1.57M | ﹤0.01% |
280,788
-57,743
| -17% | -$323K |
|
2361
Inuvo
INUV
$14.3M
| $1.57M | ﹤0.01% |
121,792
+900
| +0.7% | +$13.5K |
|
|
SUNE
2362
SUNation Energy
SUNE
$10.6M
| $1.55M | ﹤0.01% |
1
| – | – |
|
|
IMH
2363
DELISTED
Impac Mortgage Holdings Inc.
IMH
| $1.55M | ﹤0.01% |
124,326
-157,274
| -56% | -$2.14M |
|
2364
EVI Industries
EVI
$209M
| $1.55M | ﹤0.01% |
81,600
-5,900
| -7% | -$105K |
|
2365
Chemung Financial Corp
CHMG
$401M
| $1.54M | ﹤0.01% |
39,100
+4,800
| +14% | +$173K |
|
|
SNMP
2366
DELISTED
Evolve Transition Infrastructure LP
SNMP
| $1.54M | ﹤0.01% |
3,264
-2,643
| -45% | -$1.06M |
|
|
WNRL
2367
DELISTED
Western Refining Logistics, LP
WNRL
| $1.52M | ﹤0.01% |
59,834
-29,971
| -33% | -$716K |
|
|
CNCO
2368
DELISTED
Cencosud S.A.
CNCO
| $1.52M | ﹤0.01% |
163,600
-40,200
| -20% | -$357K |
|
|
CEA
2369
DELISTED
China Eastern Airlines
CEA
| $1.51M | ﹤0.01% |
52,800
-1,000
| -2% | -$26.7K |
|
2370
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $1.51M | ﹤0.01% |
38,000
+2,000
| +6% | +$77.2K |
|
|
WG
2371
DELISTED
Willbros Group
WG
| $1.5M | ﹤0.01% |
549,200
-129,600
| -19% | -$378K |
|
2372
EPAM Systems
EPAM
$5.29B
| $1.5M | ﹤0.01% |
19,900
-24,500
| -55% | -$1.71M |
|
2373
Independent Bank
INDB
$4.04B
| $1.5M | ﹤0.01% |
23,108
-57,200
| -71% | -$3.69M |
|
2374
Ingles Markets
IMKTA
$1.67B
| $1.5M | ﹤0.01% |
34,774
+22,474
| +183% | +$1.03M |
|
|
VCO
2375
DELISTED
Vina Concha Y Toro 50 Shrs
VCO
| $1.5M | ﹤0.01% |
44,100
+3,400
| +8% | +$114K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.